CN110857284B - 一种合成n-甲基脂肪胺的方法 - Google Patents

一种合成n-甲基脂肪胺的方法 Download PDF

Info

Publication number
CN110857284B
CN110857284B CN201810967988.7A CN201810967988A CN110857284B CN 110857284 B CN110857284 B CN 110857284B CN 201810967988 A CN201810967988 A CN 201810967988A CN 110857284 B CN110857284 B CN 110857284B
Authority
CN
China
Prior art keywords
reaction
set forth
amine
aliphatic amine
methanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201810967988.7A
Other languages
English (en)
Other versions
CN110857284A (zh
Inventor
李峰
汤亚文
胥婧
孟冲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing University of Science and Technology
Original Assignee
Nanjing University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing University of Science and Technology filed Critical Nanjing University of Science and Technology
Priority to CN201810967988.7A priority Critical patent/CN110857284B/zh
Publication of CN110857284A publication Critical patent/CN110857284A/zh
Application granted granted Critical
Publication of CN110857284B publication Critical patent/CN110857284B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/023—Preparation; Separation; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

本发明公开了一种合成N‑甲基脂肪胺的方法，以脂肪胺和甲醇为原料，采用过渡金属铱催化剂催化N‑甲基化反应。本发明使用无毒无害的水做溶剂，避免使用有机试剂；反应只生成水作为副产物，无环境危害；反应原子经济性高，具有广阔的应用前景。

Description

一种合成N-甲基脂肪胺的方法
技术领域
本发明属有机合成化学技术领域，具体涉及一种合成N-甲基脂肪胺的方法。
背景技术
脂肪胺甲基化反应是一类重要的有机合成反应，其广泛应用于医药、染料、颜料和农业领域。(a.K.L.Seim,A.Obermeyer and M.B.Francis,J.Am.Chem.Soc.,2011,133,16970-16976.b.L.G.Xie and Z.X.Wang,Angew.Chem.,Int.Ed.,2011,50,4901-4904.c.D.A.Davis,A.Hamilton,J.Yang,L.D.Cremar,D.Van Gough,S.L.Potisek,M.T.Ong,P.V.Braun,T.J.Martinez,S.R.White,J.S.Moore and N.R.Sottos,Nature,2009,459,68-72.d.A.Yu,Z.Gu,D.Chen,W.He,P.Tan and J.Xiang,Catal.Commun.,2009,11,162-166.)
近年来，通过使用钌，铱，锰等金属催化剂，激活甲醇作为甲基化试剂已经引起了广泛关注。(a.Huh,K.T.；Tsuji,Y.；Kobayashi,M.；Okuda,F.；Watanabe,Y.Chem.Lett.1988,17,449-452；b.Dang,T.T.；Ramalingam,B.；Seayad,M.A.ACSCatal.2015,5,4082-4088.c.Li,F.；Xie,J.J.；Shan,H.；Sun,C.；L.Chen,L.RSC Adv.2012,2,8645-8652.)该类反应的优势：使用价格低廉低毒的甲醇为甲基化试剂，反应的副产物只生成水的生成，对环境友好，反应原子经济性高。但是这类反应仍需较高温度，反应时间长，大量的强碱，氮气保护等苛刻条件。
最近，我们课题组使用金属催化剂作为催化剂实现了利用醇作为甲基化试剂N-甲基化脂肪胺。(RSC Adv.,2012,2,8645-8652；Org.Lett.2017,19,5790-5793).
然而，之前报导的反应都在大量的甲醇作为溶剂中进行，容易造成溶剂的浪费和环境污染。
发明内容
本发明的目的在于提供种合成N-甲基脂肪胺的方法。
本发明通过下述技术方案实现：一种种合成N-甲基脂肪胺(式Ⅰ)的方法，
Figure BDA0001775446720000011
其包含使胺(式Ⅱ)
Figure BDA0001775446720000012
与甲醇(式III)反应
MeOH
III
反应是在过渡金属铱催化剂存在下发生，其反应通式为
Figure BDA0001775446720000021
其中，R、R’选自C1-C4烷基。
本发明通过下述具体步骤实现：
在反应容器中，加入胺、甲醇、铱络合物催化剂、碱，混合物反应数小时后，冷却到室温，旋转蒸发除去溶剂，然后通过柱分离，得到目标化合物。
其中所述的过渡金属铱催化剂为金属铱络合物[{Ir(Cp*)(OH2)Cl}2(thbpym)][Cl]2，其结构如下所示：
Figure BDA0001775446720000022
碱选用氢氧化钾，碱对于胺的摩尔量为1equiv，过渡金属铱催化剂的用量为胺的1mol％，甲醇与水的体积比为1:3，反应在130℃下反应12小时。
同现有技术相比，本发明使用水溶性过渡金属催铱化剂，反应展现出以下显著的优点，使用水为溶剂，因此避免了使用甲醇作为溶剂，因而该反应符合绿色化学的要求，具有广阔的发展前景。
具体实施方式
展示一下实例来说明本发明的某些实施例，且不应解释为限制本发明的范围。对本发明公开的内容可以同时从材料，方法和反应条件上进行许多改进，变化和改变。所有这些改进，变化和改变均确定地落入本发明的精神和范围之内。
实施例1:2-甲基-1,2,3,4-四氢异喹啉
2-methyl-1,2,3,4-tetrahydroisoquinoline
Figure BDA0001775446720000023
将四氢异喹啉(66.6mg,0.5mmol)、铱催化剂(5.1mg,0.005mmol,1mol％)、氢氧化钾(28mg,0.5mmol,1equiv)、和甲醇(0.3mL)、水(0.9mL)依次加入到10mL克氏管中。反应混合物在反应容器中130℃下反应12小时后，冷却到室温。旋转蒸发除掉溶剂，然后通过柱层析(展开剂：石油醚/乙酸乙酯)得到纯净的目标化合物，产率：87％。
1H NMR(500MHz,CDCL3)δ7.20-7.07(m,3H,ArH),7.06-6.98(m,1H,ArH),3.58(s,2H,CH2),2.93(t,J＝6.0Hz,2H,CH2),2.69(t,J＝6.0Hz,2H,CH2),2.46(s,3H,CH3)；13C{1H}NMR(125MHz,CDCL3)δ134.9,133.9,128.7,126.5,126.2,125.7,58.1,53.1,46.3,29.4.
实施例2:4,4′-三亚甲基双(1-甲基哌啶)
1,3-bis(1-methylpiperidin-4-yl)propane
Figure BDA0001775446720000031
将1,3-二(4-哌啶基)丙烷(105.2mg,0.5mmol)、铱催化剂(5.1mg,0.005mmol,1mol％)、氢氧化钾(28mg,0.5mmol,1equiv)、和甲醇(0.3mL)、水(0.9mL)依次加入到10mL克氏管中。反应混合物在反应容器中130℃下反应12小时后，冷却到室温。旋转蒸发除掉溶剂，然后通过柱层析(展开剂：石油醚/乙酸乙酯)得到纯净的目标化合物，产率：85％。
1H NMR(500MHz,CDCL3)δ2.67(d,J＝11.6Hz,4H),2.10(s,6H),1.73(t,J＝11.3Hz,4H),1.51(d,J＝11.2Hz,4H),1.20-1.00(m,12H)；13C{1H}NMR(125MHz,CDCL3)δ56.0,46.5,36.7,35.1,32.4,23.8.。
实施例3:1,4-二甲基哌嗪
1,4-dimethylpiperazine
Figure BDA0001775446720000032
将哌嗪(43.1mg,0.5mmol)、铱催化剂(5.1mg,0.005mmol,1mol％)、氢氧化钾(28mg,0.5mmol,1equiv)、和甲醇(0.3mL)、水(0.9mL)依次加入到10mL克氏管中。反应混合物在反应容器中130℃下反应12小时后，冷却到室温。旋转蒸发除掉溶剂，然后通过柱层析(展开剂：石油醚/乙酸乙酯)得到纯净的目标化合物，产率：83％
1H NMR(500MHz,CDCL3)δ3.20-2.00(s,8H),2.25-2.21(m,6H)；13C{1H}NMR(125MHz,CDCl3)δ55.2,46.1.。

Claims (7)

1.合成N-甲基脂肪胺Ⅰ的方法，其特征是，
Figure FDA0003942114310000011
其包含使胺Ⅱ
Figure FDA0003942114310000012
与甲醇III反应
MeOH
|||
反应是在过渡金属铱催化剂和碱存在下发生，
其中，R、R’选自C1-C4烷基；
过渡金属铱催化剂结构如下：
Figure FDA0003942114310000013
2.根据权利要求1所述的方法，其特征是，催化剂用量相对胺摩尔量为1mol％。
3.根据权利要求1所述的方法，其特征是，碱为氢氧化钾。
4.根据权利要求1所述的方法，其特征是，碱摩尔量相对于胺摩尔量为1当量。
5.根据权利要求1所述的方法，其特征是，反应体系溶剂为体积比为1:3的甲醇和水的混合溶剂。
6.根据权利要求1所述的方法，其特征是，反应温度为130℃。
7.根据权利要求1所述的方法，其特征是，反应时间为12小时。
CN201810967988.7A 2018-08-23 2018-08-23 一种合成n-甲基脂肪胺的方法 Active CN110857284B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810967988.7A CN110857284B (zh) 2018-08-23 2018-08-23 一种合成n-甲基脂肪胺的方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810967988.7A CN110857284B (zh) 2018-08-23 2018-08-23 一种合成n-甲基脂肪胺的方法

Publications (2)

Publication Number Publication Date
CN110857284A CN110857284A (zh) 2020-03-03
CN110857284B true CN110857284B (zh) 2023-02-14

Family

ID=69635263

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810967988.7A Active CN110857284B (zh) 2018-08-23 2018-08-23 一种合成n-甲基脂肪胺的方法

Country Status (1)

Country Link
CN (1) CN110857284B (zh)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103172523A (zh) * 2011-12-23 2013-06-26 南京理工大学 选择性n-甲基化伯胺的方法
CN107778182A (zh) * 2016-08-29 2018-03-09 南京理工大学 一种合成n‑烷基芳胺的方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103172523A (zh) * 2011-12-23 2013-06-26 南京理工大学 选择性n-甲基化伯胺的方法
CN107778182A (zh) * 2016-08-29 2018-03-09 南京理工大学 一种合成n‑烷基芳胺的方法

Also Published As

Publication number Publication date
CN110857284A (zh) 2020-03-03

Similar Documents

Publication Publication Date Title
EP3260441B1 (en) Method for preparing formamide compound
US20220289666A1 (en) Method for preparing formamide compounds via hydrogenation of carbon dioxide catalyzed by porous materials
CN108794400B (zh) 一种阳离子带氨基的含有氨基酸的离子液体及其制备方法和应用
US9434665B2 (en) Ruthenium complex and method for preparing methanol and diol
CN107827816B (zh) 一种氧化石墨烯催化甲酰化反应合成甲酰胺衍生物的方法
CN109422654B (zh) 合成脂肪胺甲基化化合物的方法
CN110857284B (zh) 一种合成n-甲基脂肪胺的方法
CN110885292B (zh) β-氨基醇类化合物的合成方法
CN107827817B (zh) 一种钼催化甲酰化反应合成甲酰胺衍生物的方法
CN114105972B (zh) 一种辛克宁衍生物及其在高光学纯茚虫威中间体制备中的应用
CN113999125B (zh) 2-甲氧基乙胺的制备方法
CN107892670A (zh) 一种钴催化甲酰化反应合成甲酰胺衍生物的方法
CN111229312B (zh) 一种无溶剂催化剂及其制备方法和应用
CN110878025A (zh) 一种芳香类硝基化合物还原成芳香胺类化合物的方法
CN108727179B (zh) 一种α-烯丙基取代的α,β-不饱和酮、酯或腈化合物的合成方法
CN107739334B (zh) Cu-MOF型催化剂在制备多取代吡啶衍生物中的应用
CN110545912A (zh) 用于由d2o制备氘代乙醇的方法
CN112409186B (zh) 一种在水中合成n-甲基苯胺的方法
CN104289215B (zh) 用于尿素和乙醇合成碳酸二乙酯的催化剂及其制备方法和应用
KR101585030B1 (ko) 하이드라자이드의 제조 방법
CN107721796B (zh) 一种含取代炔基环丙化合物的制备方法
CN108299236B (zh) 一种α-氰基丙烯酸酯类化合物的合成方法
CN110652979B (zh) 采用混合催化剂制备碳酸甘油酯的方法
CN116655454A (zh) 一种顺-1,4-环己二醇的合成方法
CN106748635B (zh) 一种三氟丁炔基苯化合物的制备方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB03 Change of inventor or designer information

Inventor after: Li Feng

Inventor after: Tang Yawen

Inventor after: Xu Jing

Inventor after: Meng Chong

Inventor before: Tang Yawen

Inventor before: Xu Jing

Inventor before: Meng Chong

Inventor before: Li Feng

CB03 Change of inventor or designer information
GR01 Patent grant
GR01 Patent grant